Histopathological analysis of 990 CRC patient tumor samples revealed increased overall CD4 expression in the TMA, which was associated with a significant increase in survival time (chisq(1) = 7.2973, p = 0.0069). This evidence concerns the gene CD4 and colorectal carcinoma.